ARTICLE | Clinical News
REGN910: Phase Ib started
November 5, 2012 8:00 AM UTC
Regeneron disclosed in its 3Q12 earnings that in September it began an open-label Phase Ib trial to evaluate multiple ascending-doses of REGN910 plus Zaltrap ziv-aflibercept in about 40 patients with...